« Previous
Next »
The Journal of Urology
Volume 181, Issue 3
, Pages
956-962
, March 2009
Adjuvant Radiotherapy for Pathological T3N0M0 Prostate Cancer Significantly Reduces Risk of Metastases and Improves Survival: Long-Term Followup of a Randomized Clinical Trial
Study received approval from individual institutional review boards of the participating institutions.
Supported by Public Health Service Cooperative Agreement grants awarded by the National Cancer Institute, Department of Health and Human Services: CA38926, CA32102, CA14028, CA58416, CA58658, CA42777, CA27057, CA46136, CA35431, CA58882, CA12644, CA58861, CA35090, CA37981, CA76429, CA04919, CA76132, CA35119, CA35178, CA35176, CA46282, CA67575, CA45377, CA46113, CA74647, CA35261, CA049020, CA20319, CA76447, CA58723, CA12213, CA22433, CA46441, and by the National Cancer Institute of Canada Grant PR-2.
PII: S0022-5347(08)03059-0
doi: 10.1016/j.juro.2008.11.032
© 2009 American Urological Association. Published by Elsevier Inc. All rights reserved.
« Previous
Next »
The Journal of Urology
Volume 181, Issue 3
, Pages
956-962
, March 2009

